Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency

Muscle and Nerve

Volumn 33, Issue 1, 2006, Pages 120-126

  Higashi, Keiko ^a   Higuchi, Itsuro ^a   Niiyama, Takahito ^a   Uchida, Yuichi ^a   Shiraishi, Tadafumi ^a   Hashiguchi, Akihiro ^a   Saito, Akiko ^a   Horikiri, Takashi ^a   Suehara, Masahito ^b   Arimura, Kimiyoshi ^a   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b National Hospital Organization Okinawa National Hospital   (Japan)

Author keywords

Collagen VI; Fibronectin receptor; NG2 proteoglycan; Tenascin C; Ullrich's disease

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN TYPE 6; NG2 PROTEOGLYCAN; PROTEOGLYCAN; TENASCIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CELL ADHESION; CELL CULTURE; CELL MEMBRANE; CLINICAL FEATURE; COLLAGEN TYPE VI DEFICIENCY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN TISSUE; MALE; MUSCLE CONTRACTURE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SKELETAL MUSCLE; SKIN; SYMPTOM; ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UPREGULATION;

ADULT; ANTIGENS; CELL MEMBRANE; COLLAGEN TYPE VI; DOWN-REGULATION; EXTRACELLULAR MATRIX; FRAMESHIFT MUTATION; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; PROTEOGLYCANS; SKIN; SYNDROME; TENASCIN; UP-REGULATION;

EID: 30344438543     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20449     Document Type: Article

References (37)

1. Baker NL, Morgelin M, Peat R, Goemans N, North KN, Bateman JF, et al. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet 2005;14:279-293.
2. Bidanset DJ, Guidry C, Rosenberg LC, Choi HU, Timpl R, Hook M. Binding of the proteoglycan decorin to collagen type VI. J Biol Chem 1992;267:5250-5256.
3. Brown JC, Mann K, Wiedemann H, Timpl R. Structure and binding properties of collagen type XIV isolated from human placenta. J Cell Biol 1993;120:557-567.
4. Burg MA, Tillet E, Timpl R, Stallcup WB. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J Biol Chem 1996;271:26110-26116.
5. Camacho Vanegas O, Bertini E, Zhang RZ, Petrini S, Minosse C, Sabatelli P, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001;98:7516-7521.
6. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell 1988;53:383-390.
7. Demir E, Sabatelli P, Allamand V, Ferreiro A, Moghadaszadeh B, Makrelouf M, et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet 2002;70:1446-1458.
8. Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, et al. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 1999;19:8778-8788.
9. Grako KA, Ochiya T, Barritt D, Nishiyama A, Stallcup WB. PDGF a-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. J Cell Sci 1999;112:905-915.
10. Grako K, Stallcup WB. Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp Cell Res 1995;221:231-240.
11. Gullberg D, Velling T, Sjoberg G, Salmivirta K, Gaggero B, Tiger CF, et al. Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis. Neuromuscul Disord 1997;7:39-54.
12. Hedbom E, Heinegard D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 1993;268:27307-27312.
13. Higuchi I, Horikiri T, Niiyama T, Suehara M, Shiraishi T, Hu J, et al. Pathological characteristics of skeletal muscle in Ullrich's disease with collagen VI deficiency. Neuromuscul Disord 2003;13:310-316.
14. Higuchi I, Niiyama T, Uchida Y, Inose M, Nakagawa M, Arimura K, et al. Multiple episodes of thrombosis in a patient with Becker muscular dystrophy with marked expression of utrophin on the muscle cell membrane. Acta Neuropathol 1999;98:313-316.
15. Higuchi I, Shiraishi T, Hashiguchi T, Suehara M, Niiyama T, Nakagawa M, et al. Frameshift mutation in the collagen VI gene causes Ullrich's disease. Ann Neurol 2001;50:261-265.
16. Higuchi I, Suehara M, Iwaki H, Nakagawa M, Arimura K, Osame M. Collagen VI deficiency in Ullrich's disease. Ann Neurol 2001;49:544.
17. Hu J, Higuchi I, Shiraishi T, Suehara M, Niiyama T, Horikiri T, et al. Fibronectin receptor reduction in skin and fibroblasts of patients with Ullrich's disease. Muscle Nerve 2002;26:696-701.
18. Jones PL, Jones FS. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 2000;19:581-596.
19. Keene DR, Engvall E, Glanville RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J Cell Biol 1988;107:1995-2006.
20. Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem 1997;272:26522-26529.
21. Martin S, Levine AK, Chen ZJ, Ughrin Y, Levine JM. Deposition of the NG2 proteoglycan at nodes of Ranvier in the peripheral nervous system. J Neurosci 2001;21:8119-8128.
22. McDevitt CA, Marcelino J, Tucker L. Interaction of intact type VI collagen with hyaluronan. FEBS Lett 1991;294:167-170.
23. Muller-Felber W, Toepfer M, Muller T, Muller-Hocker J, Fischer P, Lochmuller H, et al. Tenascin is a useful marker in the diagnosis of inflammatory myopathies. Eur J Med Res 1998;3:281-287.
24. Niiyama T, Higuchi I, Hashiguchi T, Suehara M, Uchida Y, Horikiri T, et al. Capillary changes in skeletal muscle of patients with Ullrich's disease with collagen VI deficiency. Acta Neuropathol 2003;106:137-142.
25. Niiyama T, Higuchi I, Suehara M, Hashiguchi T, Shiraishi T, Nakagawa M, et al. Electron microscopic abnormalities of skeletal muscle in patients with collagen VI deficiency in Ullrich's disease. Acta Neuropathol 2002;104:67-71.
26. Nishiyama A, Stallcup WB. Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. Mol Biol Cell 1993;4:1097-1108.
27. Pan TC, Zhang RZ, Sudano DG, Marie SK, Bonnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: A heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet 2003;73:355-369.
28. Petrini S, Tessa A, Carrozzo R, Verardo M, Pierini R, Rizza T, et al. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies. Mol Cell Neurosci 2003;23:219-231.
29. Sage EH, Bornstein P. Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J Biol Chem 1991;266:14831-14834.
30. Stallcup WB, Dahlin K, Healy P. Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J Cell Biol 1990;111:3177-3188.
31. Tillet E, Gential B, Garrone R, Stallcup WB. NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI. J Cell Biochem 2002;86:726-736.
32. Tillet E, Wiedemann H, Golbik R, Pan TC, Zhang RZ, Mann K, et al. Recombinant expression and structural and binding properties of alpha 1 (VI) and alpha 2 (VI) chains of human collagen type VI. Eur J Biochem 1994;221:177-185.
33. Ullrich O. Kongenitale atonisch-sklerotische Muskeldystrophie ein weiterer Typus der heredodegenerativen Erkrankungen des neuromuskularen Systems. Z Ges Neurol Psychiat 1930;126:171-201.
34. Usuki F, Yamashita A, Higuchi I, Ohnishi T, Shiraishi T, Osame M, et al. Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease. Ann Neurol 2004;55:740-744.
35. Vogel KG, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984;223:587-597.
36. Watson RE, Ball SG, Craven NM, Boorsma J, East CL, Shuttleworth CA, et al. Distribution and expression of type VI collagen in photoaged skin. Br J Dermatol 2001;144:751-759.
37. Wiberg C, Hedbom E, Khairullina A, Lamande SR, Oldberg A, Timpl R, et al. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J Biol Chem 2001;276:18947-18952.